# Safety and Efficacy of Propionyl-L-Carnitine in the Treatment of Peripheral Arterial Disease (Intermittent Claudication)

> **NCT00399919** · PHASE3 · COMPLETED · sponsor: **Sigma-Tau Research, Inc.** · enrollment: 69 (actual)

## Conditions studied

- Peripheral Vascular Diseases
- Intermittent Claudication

## Interventions

- **DRUG:** Propionyl-L-Carnitine
- **DRUG:** PLC

## Key facts

- **NCT ID:** NCT00399919
- **Lead sponsor:** Sigma-Tau Research, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2011-08-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00399919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00399919, "Safety and Efficacy of Propionyl-L-Carnitine in the Treatment of Peripheral Arterial Disease (Intermittent Claudication)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00399919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*